TC-S 7005 is a Polo-like kinases (Plks) inhibitor with IC 50 s of 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively.
性状
Solid
IC50 & Target[1][2]
PLK2 4 nM (IC50) PLK3 24 nM (IC50u
体外研究(In Vitro)
TC-S 7005 markedly induces myofibroblast differentiation and reduces fibroblast proliferation rates. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Proliferation Assay
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Hanan EJ, et al. Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors. Bioorg Med Chem Lett. 2008 Oct 1;18(19):5186-9.[2]. Stephan Reinhard Künzel, et al. Hypoxia-induced epigenetic silencing of polo-like kinase 2 promotes fibrosis in atrial fibrillation. bioRxiv 445098
溶解度数据
In Vitro: DMSO : 125 mg/mL (347.82 mM; Need ultrasonic)配制储备液